These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 24018547)

  • 1. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
    Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression.
    Gorgulu Y; Caliyurt O
    Brain Res Bull; 2009 Sep; 80(3):158-62. PubMed ID: 19576267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients.
    Zanardini R; Gazzoli A; Ventriglia M; Perez J; Bignotti S; Rossini PM; Gennarelli M; Bocchio-Chiavetto L
    J Affect Disord; 2006 Mar; 91(1):83-6. PubMed ID: 16448701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation.
    Giese M; Beck J; Brand S; Muheim F; Hemmeter U; Hatzinger M; Holsboer-Trachsler E; Eckert A
    J Psychiatr Res; 2014 Dec; 59():1-7. PubMed ID: 25258340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
    Alevizos B; Alevizos E; Leonardou A; Zervas I
    Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine serum levels remain unchanged during lithium augmentation of antidepressants in major depression.
    Ricken R; Busche M; Schlattmann P; Himmerich H; Bopp S; Bschor T; Richter C; Stamm TJ; Heinz A; Hellweg R; Lang UE; Adli M
    J Psychiatr Res; 2018 Jan; 96():203-208. PubMed ID: 29101798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
    Piccinni A; Marazziti D; Catena M; Domenici L; Del Debbio A; Bianchi C; Mannari C; Martini C; Da Pozzo E; Schiavi E; Mariotti A; Roncaglia I; Palla A; Consoli G; Giovannini L; Massimetti G; Dell'Osso L
    J Affect Disord; 2008 Jan; 105(1-3):279-83. PubMed ID: 17553570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.
    Yasui-Furukori N; Tsuchimine S; Nakagami T; Fujii A; Sato Y; Tomita T; Yoshizawa K; Inoue Y; Kaneko S
    Hum Psychopharmacol; 2011 Apr; 26(3):194-200. PubMed ID: 21638327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
    Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
    J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum brain-derived neurotrophic factor and glucocorticoid receptor levels in lymphocytes as markers of antidepressant response in major depressive patients: a pilot study.
    Rojas PS; Fritsch R; Rojas RA; Jara P; Fiedler JL
    Psychiatry Res; 2011 Sep; 189(2):239-45. PubMed ID: 21616544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression.
    Bschor T; Baethge C; Adli M; Lewitzka U; Eichmann U; Bauer M
    J Psychiatry Neurosci; 2003 May; 28(3):210-6. PubMed ID: 12790161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.